Negotiated Procedure for the Supply of the Medicinal Specialty PAXLOVID Indicated for the Treatment of Coronavirus Disease (Covid-19) Required by the Healthcare Companies of the Abruzzo Region

AREACOM, the Regional Agency of Abruzzo for Procurement, is conducting a negotiated procedure without prior tender notice for the supply of the medicinal specialty PAXLOVID. This drug is indicated for the treatment of COVID-19 and is required by the healthcare companies within the Abruzzo Region. The contract, identified by CIG B10DD5CDD6, falls under the Supplies category. The procedure is a negotiated one without prior publication of a tender notice. The location for this supply is L'Aquila. The estimated value for this procurement is substantial at EUR 17,414,531.28. The tender documents are available on the Giada AREacom portal. The contract was awarded to PFIZER for EUR 7,995,783.60. This procurement is critical for the region's healthcare system to manage and treat COVID-19 cases effectively.

This is a supplies contract in the general supplies sector, with a focus on General Supplies. Located in Italy, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 17.4 million.

Published through ANAC (Italy), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the general supplies sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.